Download or read online books in PDF, EPUB and Mobi Format. Click Download or Read Online button to get book now. This site is like a library, Use search box in the widget to get ebook that you want.

The Business of Bioscience

The Business of Bioscience Author Craig D. Shimasaki
ISBN-10 1441900640
Release 2009-09-18
Pages 269
Download Link Click Here

My journey into this fascinating field of biotechnology started about 26 years ago at a small biotechnology company in South San Francisco called Genentech. I was very fortunate to work for the company that begat the biotech industry during its formative years. This experience established a solid foundation from which I could grow in both the science and business of biotechnology. After my fourth year of working on Oyster Point Boulevard, a close friend and colleague left Genentech to join a start-up biotechnology company. Later, he approached me to leave and join him in of all places – Oklahoma. He persisted for at least a year before I seriously considered his proposal. After listening to their plans, the opportunity suddenly became more and more intriguing. Finally, I took the plunge and joined this ent- preneurial team in cofounding and growing a start-up biotechnology company. Making that fateful decision to leave the security of a larger company was extremely difficult, but it turned out to be the beginning of an entrepreneurial career that forever changed how I viewed the biotechnology industry. Since that time, I have been fortunate to have cofounded two other biotechnology com- nies and even participated in taking one of them public. During my career in these start-ups, I held a variety of positions, from directing the science, operations, regulatory, and marketing components, to subsequently becoming CEO.



Ethics and the Business of Bioscience

Ethics and the Business of Bioscience Author Margaret L. Eaton
ISBN-10 0804742502
Release 2004
Pages 534
Download Link Click Here

Businesses that produce bioscience products—gene tests and therapies, pharmaceuticals, vaccines, and medical devices—are regularly confronted with ethical issues concerning these technologies. Conflicts exist between those who support advancements in bioscience and those who fear the consequences of unfettered scientific license. As the debate surrounding bioscience grows, it will be increasingly important for business managers to consider the larger consequences of their work. This groundbreaking book follows industry research, development, and marketing of medical and bioscience products across a variety of fields, including biotechnology, pharmaceuticals, and bio-agriculture. Compelling and current case studies highlight the ethical decisions business managers frequently face. With the increasing visibility and public expectation placed on businesses in this sector, managers need to understand the ethical and social issues. This book addresses that need and provides a framework for incorporating ethical analysis in business decision making.



Biotechnology Entrepreneurship

Biotechnology Entrepreneurship Author Craig Shimasaki
ISBN-10 9780124047471
Release 2014-04-08
Pages 488
Download Link Click Here

As an authoritative guide to biotechnology enterprise and entrepreneurship, Biotechnology Entrepreneurship and Management supports the international community in training the biotechnology leaders of tomorrow. Outlining fundamental concepts vital to graduate students and practitioners entering the biotech industry in management or in any entrepreneurial capacity, Biotechnology Entrepreneurship and Management provides tested strategies and hard-won lessons from a leading board of educators and practitioners. It provides a ‘how-to’ for individuals training at any level for the biotech industry, from macro to micro. Coverage ranges from the initial challenge of translating a technology idea into a working business case, through securing angel investment, and in managing all aspects of the result: business valuation, business development, partnering, biological manufacturing, FDA approvals and regulatory requirements. An engaging and user-friendly style is complemented by diverse diagrams, graphics and business flow charts with decision trees to support effective management and decision making. Provides tested strategies and lessons in an engaging and user-friendly style supplemented by tailored pedagogy, training tips and overview sidebars Case studies are interspersed throughout each chapter to support key concepts and best practices. Enhanced by use of numerous detailed graphics, tables and flow charts



BioIndustry Ethics

BioIndustry Ethics Author David L. Finegold
ISBN-10 0080492517
Release 2005-07-19
Pages 384
Download Link Click Here

This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics.



A Biotech Manager s Handbook

A Biotech Manager s Handbook Author M O'Neill
ISBN-10 9781908818157
Release 2012-05-02
Pages 414
Download Link Click Here

A biotech manager's handbook lays out - in a simple, straightforward manner - for the manager or would-be entrepreneur the basic principles of running a biotech company. Most managers in biotechnology companies are working in their first company or in their first managerial role. Their expertise and experience in the scientific part of the work can be taken as a given but there is a whole range of other skills to be learned and areas of expertise to come to terms with. Small companies do not have big budgets to hire people or time to become an expert in so many areas. The book starts by outlining the state of the biopharmaceutical industry and goes on to explain the importance of planning (no matter what the size of the company). Succeeding chapters deal with the basics of intellectual property, perspectives from a university technology transfer office and how to raise some initial funding from an investor and entrepreneur. No other 'how to' manual exists for this sector Written by a range of expert professionals in each area, all in one book Is the only 'bench to bedside' book covering the whole spectrum of development



Lords Of The Harvest

Lords Of The Harvest Author Dan Charles
ISBN-10 9780786723768
Release 2008-08-04
Pages 368
Download Link Click Here

Biotech companies are creating designer crops with strange powers-from cholesterol-reducing soybeans to tobacco plants that act as solar-powered pharmaceutical factories. They promise great benefits: better health for consumers and more productive agriculture. But the vision has a dark side. In Lords of the Harvest, Daniel Charles tells the real story behind "Frankenstein foods"-the story you won't hear from the biotech companies or their fiercest opponents. He reveals for the first time the cutthroat scientific competition and backroom business deals that led to the first genetically engineered foods. And he exposes the secrets of campaigns on both sides of the Atlantic aimed at bringing down the biotech industry. A riveting tale of boundless ambition, political intrigue, and the quest for knowledge, Lords of the Harvest is ultimately a story of idealism and conflicting dreams about the shape of a better world.



Biotechnology Valuation

Biotechnology Valuation Author Karl Keegan
ISBN-10 9780470741344
Release 2009-01-15
Pages 216
Download Link Click Here

The first book to provide a simple and practical means of valuing biotech companies The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them Praise for Biotechnology Valuation "Keegan states that the valuation of Biotech companies is as much an art as a science. This brief but comprehensive review of the skills and knowledge required, not of just the financial market and sentiment, but also of the technical attributes of a company and the drug development and regulatory hurdles that must be overcome, highlights the importance of the breadth of understanding required. Biotech investing is not for the timid, but it can bring substantial returns. Keegan's book, punctuated with his personal experience and opinions, is a good place to start." —Chris Blackwell, Chief Executive, Vectura Group plc "A user-friendly, yet thorough discussion of a notoriously difficult topic. Dr Keegan's book is a fine resource for both business types and academicians." —Steve Winokur, Managing Director, CanaccordAdams "A highly readable and comprehensive explanation of the technical and commercial parameters that influence biotechnology companies at all stages of development, providing clear context for selection from the toolkit of valuation methodologies the author recommends to assess company and product performance, or ascribe value." —Dr L.M. Allan, Director, Bioscience Enterprise Programme, University of Cambridge "A fabulous approach to a difficult topic." —Deirdre Y. Gillespie, MD, President & CEO, La Jolla Pharmaceutical Company



Career Opportunities in Biotechnology and Drug Development

Career Opportunities in Biotechnology and Drug Development Author Toby Freedman
ISBN-10 9780879697259
Release 2008
Pages 409
Download Link Click Here

Offers detailed information on over one hundred careers in such areas as regulatory affairs, product development, information management, and sales.



Creating Sustainable Bioeconomies

Creating Sustainable Bioeconomies Author Ivar Virgin
ISBN-10 9781317594413
Release 2016-08-25
Pages 296
Download Link Click Here

The growing global demand for food, feed and bio-based renewable material is changing the conditions for agricultural production worldwide. At the same time, revolutionary achievements in the field of biosciences are contributing to a transition whereby bio-based alternatives for energy and materials are becoming more competitive. Creating Sustainable Bioeconomies explores the prospects for biosciences and how its innovation has the potential to help countries in the North (Europe) and the South (Africa) to move towards resource efficient agriculture and sustainable bioeconomies. Throughout the book, the situations of Europe and Sub-Saharan Africa will be compared and contrasted, and opportunities for mutual learning and collaboration are explored. The chapters have been written by high profile authors and deal with a wide range of issues affecting the development of bioeconomies on both continents. This book compares and contrasts the situations of these two regions as they endeavour to develop knowledge based bioeconomies. This volume is suitable for those who are interested in ecological economics, development economics and environmental economics. It also provides action plans assisting policy-makers in both areas to support the transition to knowledge based and sustainable bioeconomies.



Modern Biotechnology

Modern Biotechnology Author J. Tramper
ISBN-10 9789086861699
Release 2011
Pages 284
Download Link Click Here

According to Greek mythology Pandora was sent down to earth upon the orders of Zeus. She was given a mysterious box which she was not allowed to open. However, Pandora was very curious and when she arrived on earth she couldn't help taking a peek inside the box. She saw that it was filled with gifts and calamities and to her astonishment they all escaped and spread throughout humanity, with all the dire consequences thereof. Only hope was left at the bottom. Figuratively speaking, Pandora's box today represents a source of much suffering. Is modern biotechnology just such a Pandora's box, as the anti-biotechnology lobby would have us believe? Or can we selectively release the gifts and turn this new Pandora's box into a Panacea? Modern biotechnology makes use of the recombinant DNA technology to genetically modify microorganisms, plants and animals in order to make them more suitable for all kinds of applications, such as cultivating food crops, baking bread, making wine, antibiotics and hormones, xenotransplantation, and gene- and stem cell therapy. The book also particularly addresses the controversial aspects of these applications.



Preparing for Future Products of Biotechnology

Preparing for Future Products of Biotechnology Author National Academies of Sciences, Engineering, and Medicine
ISBN-10 9780309452052
Release 2017-07-28
Pages 230
Download Link Click Here

Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5â€"10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology? Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.



Genentech

Genentech Author Sally Smith Hughes
ISBN-10 9780226359205
Release 2011-09-21
Pages 232
Download Link Click Here

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise. Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech’s improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech’s science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech’s founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits. Integrating the scientific, the corporate, the contextual, and the personal, Genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.



Innovation Commercialization and Start Ups in Life Sciences

Innovation  Commercialization  and Start Ups in Life Sciences Author James F. Jordan
ISBN-10 9781482210125
Release 2014-11-05
Pages 254
Download Link Click Here

Innovation is the translation of a new method, idea, or product into reality and profit. It is a process of connected steps that accumulates into your brand or reputation. However, there can be many pitfalls and wrong turns on the road to realizing this goal. Innovation, Commercialization, and Start-Ups in Life Sciences details the methodologies necessary to create a successful life sciences start-up from initiation to exit. You will gain an appreciation for the necessary data, partnership, and skills to be acquired and the constituencies that must be satisfied along the way. The book examines how life sciences start-ups can create an exit for their investors by recognizing that a liquidity event is not consummated without due diligence. Due diligence is bigger than validating accounting transactions. It ensures the company is solving an important customer problem, demonstrating sales access, and making sure that intellectual property is impervious to competitive advancement. The due diligence process supports the telling of a compelling story to customers, investors, regulators, and acquirers. Written by an expert who has worked with more than 200 life sciences start-ups during the past decade, the book discusses specific processes and investor milestones that must be navigated to align customer, funder, and acquirer needs. It examines these processes from the perspective of marketing value through a focus on the needs of individual constituents—investors, regulators, customers, and exit candidates. The book presents data and analytical processes articulating the fundable milestones for angel and venture capital. It gives you the tools needed to create branding for public investors and more.



Bioscience Lost in Translation

Bioscience   Lost in Translation Author Richard Barker
ISBN-10 9780198737780
Release 2016-09-01
Pages 240
Download Link Click Here

Medical innovation as it stands today is fundamentally unsustainable. There is a widening gap between what biomedical research promises and the impact that it is currently achieving, in terms of patient benefit and health system improvement. This book highlights the global problem of the ineffective translation of bioscience innovation into health system improvements and its consequences, analyses the underlying causative factors and provides powerful prescriptions for change to close the gap. It contrasts the progress in biomedicine with other areas of scientific and technological endeavour, such as information technology, in which there are faster and more reliable returns for society from scientific advance. It asks searching questions about whether society is right to expect so much from biomedicine and why we have become accustomed to such poor returns. Throughout the book, techniques such as stratified medicine, open innovation, adaptive development and personalised adherence are discussed and described in terms accessible to the non-specialist, and their impact on the innovation gap explored. By using examples in which bottlenecks have prevented progress, such as dementia and antibiotic-resistant infections, and in which these barriers have been overcome, such as HIV treatment, Bioscience - Lost in Translation? lays out a strategy for advancing the innovation process, presenting suggestions for how health systems can move from being passive recipients of innovation to being active participants in development.



Biotech

Biotech Author Eric J. Vettel
ISBN-10 9780812203622
Release 2013-03-01
Pages 296
Download Link Click Here

The seemingly unlimited reach of powerful biotechnologies and the attendant growth of the multibillion-dollar industry have raised difficult questions about the scientific discoveries, political assumptions, and cultural patterns that gave rise to for-profit biological research. Given such extraordinary stakes, a history of the commercial biotechnology industry must inquire far beyond the predictable attention to scientists, discovery, and corporate sales. It must pursue how something so complex as the biotechnology industry was born, poised to become both a vanguard for contemporary world capitalism and a focal point for polemic ethical debate. In Biotech, Eric J. Vettel chronicles the story behind genetic engineering, recombinant DNA, cloning, and stem-cell research. It is a story about the meteoric rise of government support for scientific research during the Cold War, about activists and student protesters in the Vietnam era pressing for a new purpose in science, about politicians creating policy that alters the course of science, and also about the release of powerful entrepreneurial energies in universities and in venture capital that few realized existed. Most of all, it is a story about people—not just biologists but also followers and opponents who knew nothing about the biological sciences yet cared deeply about how biological research was done and how the resulting knowledge was used. Vettel weaves together these stories to illustrate how the biotechnology industry was born in the San Francisco Bay area, examining the anomalies, ironies, and paradoxes that contributed to its rise. Culled from oral histories, university records, and private corporate archives, including Cetus, the world's first biotechnology company, this compelling history shows how a cultural and political revolution in the 1960s resulted in a new scientific order: the practical application of biological knowledge supported by private investors expecting profitable returns eclipsed basic research supported by government agencies.



The Biologist s Imagination

The Biologist s Imagination Author William Hoffman
ISBN-10 9780199974597
Release 2014
Pages 284
Download Link Click Here

"Scholars and policymakers alike agree that innovation in the biosciences is key to future growth. The field continues to shift and expand, and it is certainly changing the way people live their lives in a variety of ways. But despite the lion's share offederal research dollars being devoted to innovation in the biosciences, the field has yet to live up to its billing as a source of economic productivity and growth. With vast untapped potential to imagine and innovate in the biosciences, adaptation of the innovative model is needed. In The Biologist's Imagination, William Hoffman and Leo Furcht examine the history of innovation in the biosciences, tracing technological innovation from the late eighteenth century to the present and placing special emphasis on how and where technology evolves. Place is key to innovation, from the early industrial age to the rise of the biotechnology industry in the second half of the twentieth century. The book uses the distinct history of bioscientific innovation to discuss current trends as they relate to medicine, agriculture, biofuels, stem-cell research, neuroscience, and more. Ultimately, Hoffman and Furcht argue that, as things currently stand, we fall short in our efforts to innovate in the biosciences; our system of innovation is itself in need of innovation. It needs to adapt to the massive changes brought about by converging technologies, globalization in higher education as well as in finance, and increases in entrepreneurship. The Biologist's Imagination is both an analysis of past models for bioscience innovation and a forward-looking, original argument for how future models should be developed"--



Biotechnology Demystified

Biotechnology Demystified Author Sharon Walker
ISBN-10 9780071490498
Release 2006-01-05
Pages 276
Download Link Click Here

This self-teaching guide explains the basic concepts and fundamentals in all the major subtopics of biotechnology. The content advances logically from the basics of molecular and cellular biology to more complex topics such as DNA, reproductive cloning, experimental procedures, infectious diseases, immunology, the Human Genome Project, new drug discoveries, and genetic disorders.